|Articles|January 2, 2010
- Pharmaceutical Technology-01-02-2010
- Volume 34
- Issue 1
Pharmaceutical Technology North America, January 2010 (PDF)
Quality by Design, Deficiencies in Generic Drug Applications, API Growth, Topical Berberine-Hydrochloride Products
Advertisement
Articles in this issue
about 16 years ago
Understanding Biological Indicator Grow-Out Timesabout 16 years ago
Healthcare Reform Requires Room for Innovationabout 16 years ago
Pharma Faces Multiple Challenges in the Year Aheadabout 16 years ago
A Look Ahead for 2010about 16 years ago
In the Field: Report from Brazilabout 16 years ago
GSK Gets under Your Skinabout 16 years ago
Tracking API Growthabout 16 years ago
Statistical Solutions: %RSD: Friend or Foe?Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Government Shutdown: Treating Regulatory Lapses as Predictable Operational Risks
2
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
3
Rare Disease Therapies: From Niche Experiment to Strategic Growth Engine
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5